ONLINE DATABASE SEARCH - OI-LS-367-MEMO

 

1.     60096   OI-LS-367; PUBMED-OI-2/5/2007

          1,25(OH)2D3 inhibits in vitro and in vivo intracellular growth of apicomplexan parasite Toxoplasma gondii

          Rajapakse, R, Uring-Lambert, B, Andarawewa, KL, Rajapakse, RP, Abou-Bacar, A, Marcellin, L, and Candolfi, E

          J Steroid Biochem Mol Biol 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17270431&dopt=abstract

2.     60097   OI-LS-367; SCIFINDER-OI-1/29/2007

          Design and synthesis of substrate-mimic inhibitors of mycothiol-S-conjugate amidase from Mycobacterium tuberculosis

          Metaferia, Belhu B, Ray, Satyajit, Smith, Jeremy A, and Bewley, Carole A

          Bioorganic & Medicinal Chemistry Letters 2007.  17(2): 444-447

          View Data on the NIAID Therapeutics Website
HYPERLINK:

3.     60098   OI-LS-367; PUBMED-OI-2/5/2007

          Highly Efficient Ligands for Dihydrofolate Reductase from Cryptosporidium hominis and Toxoplasma gondii Inspired by Structural Analysis

          Pelphrey, PM, Popov, VM, Joska, TM, Beierlein, JM, Bolstad, ES, Fillingham, YA, Wright, DL, and Anderson, AC

          J Med Chem 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17269758&dopt=abstract

4.     60099   OI-LS-367; PUBMED-OI-2/5/2007

          Anidulafungin: a new echinocandin for candidal infections

          de la Torre, P and Reboli, AC

          Expert Rev Anti Infect Ther 2007.  5(1): 45-52

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17266452&dopt=abstract

5.     60100   OI-LS-367; SCIFINDER-OI-1/29/2007

          Preparation of oxazolidinone derivatives as antibacterial agents

          Josyula, Vara Prasad Venkata Nagendra, Boyer, Frederick Earl Jr, and Kim, Ji-Young

          PATENT:  WO 2007000644  ISSUE DATE:  20070104

          APPLICATION: 2006  PP: 38pp.

          ASSIGNEE:  (Pharmacia & Upjohn Company LLC, USA

          View Data on the NIAID Therapeutics Website
HYPERLINK:


6.     60101   OI-LS-367; PUBMED-OI-2/5/2007

          Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein

          Hartkoorn, RC, Chandler, B, Owen, A, Ward, SA, Bertel, Squire S, Back, DJ, and Khoo, SH

          Tuberculosis (Edinb) 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17258938&dopt=abstract

7.     60102   OI-LS-367; PUBMED-OI-2/5/2007

          Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study

          Goletti, D, Parracino, MP, Butera, O, Bizzoni, F, Casetti, R, Dainotto, D, Anzidei, G, Nisii, C, Ippolito, G, Poccia, F, and Girardi, E

          Respir Res 2007.  8(1): 5

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17257436&dopt=abstract

8.     60103   OI-LS-367; PUBMED-OI-2/5/2007

          Association of the Rv0679c protein with lipids and carbohydrates in Mycobacterium tuberculosis/Mycobacterium bovis BCG

          Matsuba, T, Suzuki, Y, and Tanaka, Y

          Arch Microbiol  2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17252234&dopt=abstract

9.     60104   OI-LS-367; PUBMED-OI-2/5/2007

          Nanomolar Competitive Inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor Type II Dehydroquinase

          Prazeres, VF, Sanchez-Sixto, C, Castedo, L, Lamb, H, Hawkins, AR, Riboldi-Tunnicliffe, A, Coggins, JR, Lapthorn, AJ, and Gonzalez-Bello, C

          ChemMedChem 2007.  2(2): 194-207

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17245805&dopt=abstract

10.   60105   OI-LS-367; PUBMED-OI-2/5/2007

          Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters

          Korf, M, Meyer, A, Jarczak, D, Beger, C, Manns, MP, and Kruger, M

          J Viral Hepat 2007.  14(2): 122-32

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17244252&dopt=abstract


11.   60106   OI-LS-367; PUBMED-OI-2/5/2007

          Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by Nanomolar Concentrations of HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone): a High Affinity Inhibitor of Alternative (type II) NADH Dehydrogenases

          Saleh, A, Friesen, J, Baumeister, S, Gross, U, and Bohne, W

          Antimicrob Agents Chemother 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17242151&dopt=abstract

12.   60107   OI-LS-367; PUBMED-OI-2/5/2007

          Antimicrobial activity of long-chain, water-soluble, dendritic tricarboxylato amphiphiles

          Williams, AA, Sugandhi, EW, Macri, RV, Falkinham, JO 3rd, and Gandour, RD

          J Antimicrob Chemother 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17242037&dopt=abstract

13.   60108   OI-LS-367; SCIFINDER-OI-1/29/2007

          On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis

          Greenstein Robert J, Su Liya, Haroutunian Vahram, Shahidi Azra, and Brown Sheldon T

          PLoS ONE 2007.  2: e161.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

14.   60109   OI-LS-367; PUBMED-OI-2/5/2007

          Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG

          Ramon-Garcia, S, Martin, C, De, Rossi E, and Ainsa, JA

          J Antimicrob Chemother 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17242035&dopt=abstract

15.   60110   OI-LS-367; PUBMED-OI-2/5/2007

          Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra

          Sharma, R, Muttil, P, Yadav, AB, Rath, SK, Bajpai, VK, Mani, U, and Misra, A

          J Antimicrob Chemother 2007.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17242031&dopt=abstract

16.   60111   OI-LS-367; SCIFINDER-OI-1/29/2007

          Cysteine Protease Inhibitors Block Toxoplasma gondii Microneme Secretion and Cell Invasion

          Teo Chin Fen, Zhou Xing Wang, Bogyo Matthew, and Carruthers Vern B

          Antimicrob Agents Chemother 2007.  51(2): 679-88.

          View Data on the NIAID Therapeutics Website
HYPERLINK:


17.   60112   OI-LS-367; SCIFINDER-OI-1/29/2007

          2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF); antimicrobial compound with cell cycle arrest in nosocomial pathogens

          Sung, Woo Sang, Jung, Hyun Jun, Park, Keunnam, Kim, Hyun Soo, Lee, In-Seon, and Lee, Dong Gun

          Life Sciences 2007.  80(6): 586-591

          View Data on the NIAID Therapeutics Website
HYPERLINK:

18.   60113   OI-LS-367; PUBMED-OI-2/5/2007

          AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis

          Daniel, J, Oh, TJ, Lee, CM, and Kolattukudy, PE

          J Bacteriol 2007.  189(3): 911-7

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17114269&dopt=abstract

19.   60114   OI-LS-367; SCIFINDER-OI-1/29/2007

          In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis

          Larsen, RA, Bauer, M, Brouwer, AE, Sanchez, A, Thomas, AM, Rajanuwong, A, Chierakul, W, Peacock, SJ, Day, N, White, NJ, Rinaldi, MG, and Harrison, TS

          Antimicrobial Agents and Chemotherapy 2007.  51(1): 343-345

          View Data on the NIAID Therapeutics Website
HYPERLINK:

20.   60115   OI-LS-367; SCIFINDER-OI-1/29/2007

          Cell Wall Targeting of Laccase of Cryptococcus neoformans during Infection of Mice

          Waterman Scott R, Hacham Moshe, Panepinto John, Hu Guowu, Shin Soowan, and Williamson Peter R

          Infect Immun 2007.  75(2): 714-22.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

21.   60116   OI-LS-367; SCIFINDER-OI-1/29/2007

          Antiviral compounds

          Cho, Aesop, Kim, Choung U, and Sheng, Xiaoning C

          PATENT:  WO 2007009109  ISSUE DATE:  20070118

          APPLICATION: 2006  PP: 197pp.

          ASSIGNEE:  (Gilead Sciences, Inc. USA

          View Data on the NIAID Therapeutics Website
HYPERLINK:

22.   60117   OI-LS-367; WOS-OI-1/28/2007

          Synthesis, magnetic, spectral, and antimicrobial studies of Cu(II), Ni(II) Co(II), Fe(III), and UO2(II) complexes of a new Schiff base hydrazone derived from 7-chloro-4-hydrazinoquinoline

          El-Behery, M and El-Twigry, H

          SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2007.  66(1): 28-36, 9

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243159300004

23.   60118   OI-LS-367; SCIFINDER-OI-1/29/2007

          Tandem repeats of lactoferrin-derived anti-hepatitis C virus Peptide enhance antiviral activity in cultured human hepatocytes

          Abe Ken-Ichi, Nozaki Akito, Tamura Kazushi, Ikeda Masanori, Naka Kazuhito, Dansako Hiromichi, Hoshino Hiro-O, Tanaka Katsuaki, and Kato Nobuyuki

          Microbiol Immunol 2007.  51(1): 117-25.

          View Data on the NIAID Therapeutics Website
HYPERLINK:

24.   60119   OI-LS-367; WOS-OI-1/28/2007

          Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis

          Kubendiran, G, Paramasivan, CN, Sulochana, S, and Mitchison, DA

          JOURNAL OF CHEMOTHERAPY 2006.  18(6): 617-623, 7

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243185500006

25.   60120   OI-LS-367; WOS-OI-1/28/2007

          In vitro and in vivo (animal models) antifungal activity of posaconazole

          Mallie, M

          JOURNAL DE MYCOLOGIE MEDICALE 2006.  16: S1-S8, 8

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243198400001

26.   60121   OI-LS-367; WOS-OI-1/28/2007

          Fungal citridone D having a novel phenylfuropyridine skeleton

          Fukuda, T, Sakabe, Y, Tomoda, H, and Omura, S

          CHEMICAL & PHARMACEUTICAL BULLETIN 2006.  54(12): 1659-1661, 3

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243143000008

27.   60122   OI-LS-367; WOS-OI-1/28/2007

          Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans

          Schwarz, P, Janbon, G, Dromer, F, Lortholary, O, and Dannaoui, E

          ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2007.  51(1): 383-385, 3

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243214200056

28.   60123   OI-LS-367; WOS-OI-2/4/2007

          Synthesis, crystal structure and antifungal/antibacterial activity of some novel highly functionalized benzoylaminocarbothioyl pyrrolidines

          Dondas, HA, Nural, Y, Duran, N, and Kilner, C

          TURKISH JOURNAL OF CHEMISTRY 2006.  30(5): 573-583, 11

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243366000005

29.   60124   OI-LS-367; WOS-OI-2/4/2007

          Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells

          Dahari, H, Ribeiro, RM, Rice, CM, and Perelson, AS

          JOURNAL OF VIROLOGY 2007.  81(2): 750-760, 11

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243350100032

30.   60125   OI-LS-367; WOS-OI-2/4/2007

          N(4)-tolyl-2-benzoylpyridine thiosemicarbazones and their copper(II) complexes with significant antifungal activity. Crystal structure of N(4)-para-tolyl-2-benzoylpyridine thiosemicarbazone

          Mendes, IC, Moreira, JP, Speziali, NL, Mangrich, AS, Takahashi, JA, and Beraldo, H

          JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY 2006.  17(8): 1571-1577, 7

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243386100013


31.   60126   OI-LS-367; WOS-OI-2/4/2007

          Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: Implications for antifungal therapy

          Hope, WW, Kruhlak, MJ, Lyman, CA, Petraitiene, R, Petraitis, V, Francesconi, A, Kasai, M, Mickiene, D, Sein, T, Peter, J, Kelaher, AM, Hughes, JE, Cotton, MP, Cotten, CJ, Bacher, J, Tripathi, S, Bermudez, L, Maugel, TK, Zerfas, PM, Wingard, JR, Drusano, GL, and Walsh, TJ

          JOURNAL OF INFECTIOUS DISEASES 2007.  195(3): 455-466, 12

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243237700021

32.   60127   OI-LS-367; WOS-OI-2/4/2007

          The hepatitis C virus NS3 protein: A model RNA helicase and potential drug target

          Frick, DN

          CURRENT ISSUES IN MOLECULAR BIOLOGY 2007.  9: 1-20, 20

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243237000001

33.   60128   OI-LS-367; WOS-OI-2/4/2007

          Antiplasmodial, antimycobacterial, and cytotoxic principles from Camchaya calcarea

          Vongvanich, N, Kittakoop, P, Charoenchai, P, Intamas, S, Sriklung, K, and Thebtaranonth, Y

          PLANTA MEDICA 2006.  72(15): 1427-1430, 4

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243285400015

34.   60129   OI-LS-367; WOS-OI-2/4/2007

          Synthesis and antimicrobial activity of sulfonamides and 4-(p-nitro benzoyl) piperazine incorporated fluoro quinolones

          Patel, NB and Bhagat, PR

          INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 2006.  16(2): 205-206, 2

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243578100031

35.   60130   OI-LS-367; WOS-OI-2/4/2007

          Synthesis, antimicrobial activity and QSARs of new benzoxazine-3-ones

          Alper-Hayta, S, Aki-Sener, E, Tekiner-Gulbas, B, Yildiz, I, Temiz-Arpaci, O, Yalcin, I, and Altanlar, N

          EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2006.  41(12): 1398-1404, 7

          View Data on the NIAID Therapeutics Website
HYPERLINK:

          http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243360300004